WLM PHARMA
ActiveSummary
WLM PHARMA has been active since 2024 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €58,427 and a net result of €27,289. Its solvency ranks better than 16% of 12,578 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 1.2% (low).
Group and network
Holdings and subsidiaries
1 holdingHoldings 1
-
100%
Sources: the companies' annual accounts, the acts in the Belgian Official Gazette and the LEI register. Annual accounts state the shareholders that notified the company under article 7:225 of the Code of Companies and Associations and the parent companies that consolidate it. The register of ultimate beneficial owners (UBO) is not public: who ultimately stands behind a natural person or a foreign parent is not stated here. A company that does not include these statements in its annual accounts, or does not have to, is not listed.
Connections & network
No directors read yet: 2 of 3 Gazette acts processed.